Hannah Deresiewicz | Stern Investor Relations |
Mark Iwicki | Chief Executive Officer |
Kim Brazzell | Head-R&D and Chief Medical |
Mary Reumuth | Chief Financial Officer |
Good day. My name is Shantel, and I will be your conference operator today. At this time, I would like to welcome everyone to the Kala Pharmaceuticals Second Quarter 2022 Financial Results Conference Call.
As a reminder, today's conference call is being recorded. [Operator Instructions] Hannah Deresiewicz from Stern Investor Relations, you may begin your conference.